Happy Valley (MA)

Happy Valley (MA) concentrated its July 2026 mix in Pre-Roll at 56.82% share, with Pre-Roll sales up 38.63% year over year and 14.59% month over month, while Flower held 30.88% share with parallel gains of 38.89% YoY and 15.54% MoM; together these two categories now account for 87.70% of sales in Massachusetts. At the same time, Edible contracted 31.70% YoY despite a 12.82% MoM lift to 5.89% share, and Vapor Pens declined 67.48% YoY and 17.49% MoM to 5.37% share, with Tincture & Sublingual falling 94.73% YoY and 43.72% MoM to just 0.05% share; against this, a small Topical line spiked 92.38% YoY and 189.59% MoM to 0.27% share. The pattern implies a pivot toward inhalable formats with scale, using price-adjusted momentum in Pre-Roll (average price $12.17) and Flower (average price $29.38) to offset contraction in Vapor Pens and Tincture & Sublingual, while niche bets like Topical provide optionality without diluting the core.

These shifts position Happy Valley (MA) to compete on depth within inhalables: a 7th-place rank in Pre-Roll in Massachusetts sets a clear near-term ladder, and the dual 38%+ YoY increases in both Pre-Roll and Flower suggest headroom to trade share from categories in retreat. With the brand’s overall average price down 17.25% YoY alongside Pre-Roll’s 14.59% MoM and Flower’s 15.54% MoM growth, the signal is that value-tier or promotional elasticity is working in high-velocity formats, while a 67.48% YoY decline in Vapor Pens and 94.73% YoY decline in Tincture & Sublingual argue against spreading assortment; the implication is to consolidate around the two leading pillars while using Topical’s 189.59% MoM burst as a controlled test rather than a scale candidate.